Unknown

Dataset Information

0

Combining intracellular selection with protein-fragment complementation to derive A? interacting peptides.


ABSTRACT: Aggregation of the ?-amyloid (A?) peptide into toxic oligomers is considered the primary event in the pathogenesis of Alzheimer's disease. Previously generated peptides and mimetics designed to bind to amyloid fibrils have encountered problems in solubility, protease susceptibility and the population of small soluble toxic oligomers. We present a new method that opens the possibility of deriving new amyloid inhibitors. The intracellular protein-fragment complementation assay (PCA) approach uses a semi-rational design approach to generate peptides capable of binding to A?. Peptide libraries are based on A? regions responsible for instigating amyloidosis, with screening and selection occurring entirely inside Escherichia coli. Successfully selected peptides must therefore bind A? and recombine an essential enzyme while permitting bacterial cell survival. No assumptions are made regarding the mechanism of action for selected binders. Biophysical characterisation demonstrates that binding induces a noticeable reduction in amyloid. Therefore, this amyloid-PCA approach may offer a new pathway for the design of effective inhibitors against the formation of amyloid in general.

SUBMITTER: Acerra N 

PROVIDER: S-EPMC3690830 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combining intracellular selection with protein-fragment complementation to derive Aβ interacting peptides.

Acerra Nicola N   Kad Neil M NM   Mason Jody M JM  

Protein engineering, design & selection : PEDS 20130524 7


Aggregation of the β-amyloid (Aβ) peptide into toxic oligomers is considered the primary event in the pathogenesis of Alzheimer's disease. Previously generated peptides and mimetics designed to bind to amyloid fibrils have encountered problems in solubility, protease susceptibility and the population of small soluble toxic oligomers. We present a new method that opens the possibility of deriving new amyloid inhibitors. The intracellular protein-fragment complementation assay (PCA) approach uses  ...[more]

Similar Datasets

| S-EPMC9055537 | biostudies-literature
| S-EPMC5340998 | biostudies-literature
| S-EPMC6944658 | biostudies-literature
| S-EPMC5633763 | biostudies-literature
| S-EPMC3626928 | biostudies-literature
| S-EPMC7377443 | biostudies-literature
| S-EPMC4608017 | biostudies-literature
| S-EPMC3458939 | biostudies-literature
| S-EPMC2708047 | biostudies-literature
| S-EPMC2993370 | biostudies-literature